Olympus announced today that it made a voluntary corrective action to provide further clarification on the use of certain bronchoscopes. The company’s global action aims to outline the safe and ...

Please provide your email address to receive an email when new articles are posted on . The FDA said its literature review found that leucovorin calcium can treat cerebral folate deficiency. Experts ...

Following the Trump administration's plans to explore whether a widely available generic medication called leucovorin could cure autism, GSK (NYSE:GSK), which once manufactured and marketed the ...

Act now — before it's too late. Microsoft has just issued a mandatory security update for all Windows 10 users, and this one comes with a new warning. Microsoft has now confirmed the next one of these ...

The Python team at Microsoft is continuing its overhaul of environment management in Visual Studio Code, with the August 2025 release advancing the controlled rollout of the new Python Environments ...

As Los Angeles Rams quarterback Matthew Stafford has back soreness with limited availability throughout the NFL offseason. Coach Sean McVay gave an injury update on his starter this weekend continuing ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of the monoclonal antibody drug class that has led to several deaths. Eli ...

Microsoft has released the KB5060829 preview cumulative update for Windows 11 24H2, which includes 38 changes, including improvements to the taskbar and a new PC-to-PC migration experience. The ...

(RTTNews) - Novo Nordisk (NVO) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion to update the Ozempic ...

FDA updates talazoparib and enzalutamide labeling, confirming survival benefits for HRR-mutated mCRPC, while excluding non-HRR patients. The FDA has approved an update to the labeling for talazoparib ...